Biotechnology & Healthcare
Clinical-stage and commercial therapeutics, from gene therapy to rare disease and oncology.
Family Office · Est. 1990
We invest in private and public ventures and acquisitions across biotechnology, healthcare, technology, green energy, critical metals, internet and blockchain networks.
Who we are
We have concluded over $2 billion of public market transactions. We invest from the pre-revenue and pre-clinical stage through to commercialization, and we stay involved at every step.
Where we invest
Clinical-stage and commercial therapeutics, from gene therapy to rare disease and oncology.
Tungsten, antimony, uranium and strategic minerals that supply the energy transition and defense.
Layer-1 protocols, interoperability infrastructure and digital-asset platforms.
Clean power and the materials and technology behind it.
Software, platforms and the infrastructure of the connected economy.
Acquiring undervalued businesses and building long-term value.
Portfolio
These holdings are listed for information only. Nothing here is an offer, solicitation or investment advice. Trademarks belong to their respective owners.
In Memoriam · 1935–2020
To our dear friend and Trustee Ronald. Thank you for 25 years of dedication and care.
We miss you.
Contact
For investment opportunities, partnerships or general inquiries, contact our team directly.